Poirot Laurent, Benoist Christophe, Mathis Diane
Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, One Joslin Place, Boston, MA 02215, USA.
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8102-7. doi: 10.1073/pnas.0402065101. Epub 2004 May 12.
In both human patients and murine models, the progression from insulitis to diabetes is neither immediate nor inevitable, as illustrated by the innocuous versus destructive infiltrates of BDC2.5 transgenic mice on the nonobese diabetic (NOD) versus C57BL/6.H-2g7 genetic backgrounds. Natural killer (NK)-cell-specific transcripts and the proportion of NK cells were increased in leukocytes from the aggressive BDC2.5/B6.H-2g7 lesions. NK cell participation was also enhanced in the aggressive lesions provoked by CTLA-4 blockade in BDC2.5/NOD mice. In this context, depletion of NK cells significantly inhibited diabetes development. NOD and B6.H-2g7 mice exhibit extensive variation in NK receptor expression, reminiscent of analogous human molecules. NK cells can be important players in type 1 diabetes, a role that was previously underappreciated.
在人类患者和小鼠模型中,从胰岛炎发展到糖尿病既不是即时的,也不是必然的,如BDC2.5转基因小鼠在非肥胖糖尿病(NOD)与C57BL/6.H-2g7遗传背景下无害与破坏性浸润所表明的那样。在侵袭性BDC2.5/B6.H-2g7病变的白细胞中,自然杀伤(NK)细胞特异性转录本和NK细胞比例增加。在BDC2.5/NOD小鼠中,CTLA-4阻断引发的侵袭性病变中NK细胞的参与也增强。在这种情况下,NK细胞的耗竭显著抑制糖尿病的发展。NOD和B6.H-2g7小鼠在NK受体表达上表现出广泛差异,这让人联想到类似的人类分子。NK细胞可能是1型糖尿病中的重要参与者,这一作用以前未得到充分认识。